This session convened scientists and industry experts to discuss the impact of the coronavirus pandemic on India’s biotechnology industry and prospects of its future growth. It highlighted lessons that India can learn to build a robust research ecosystem to respond to future disease outbreaks.

Recognizing the severity of the coronavirus pandemic, the Indian government announced a three-week nationwide lockdown until April 14, 2020.

Biotechnology has great potential in India, especially given that cutting-edge product development and research is underway, despite a nascent market and industry in the country.